Citation Impact
Citing Papers
The principal results of the International Immune Tolerance Study: a randomized dose comparison
2011
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Emerging and receding risks of therapeutic regimens for haemophilia
2004
Semisynthetic Src SH2 Domains Demonstrate Altered Phosphopeptide Specificity Induced by Incorporation of Unnatural Lysine Derivatives
2010 StandoutNobel
Effects of Agents, Used to Treat Bleeding Disorders, on Bleeding Time Prolonged by a Very High Dose of a Direct Thrombin Inhibitor in Anesthesized Rats and Rabbits
2001
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
2010
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
2006
International workshop on immune tolerance induction: consensus recommendations1
2007
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Recommendations for assessment, monitoring and follow‐up of patients with haemophilia
2011
The epidemiology of inhibitors in haemophilia A: a systematic review
2003
Immune tolerance induction in haemophilia: evidence and the way forward
2011
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease
2004
How were new medicines discovered?
2011 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
mRNA transcript therapy
2014 StandoutNobel
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations
2011
Idarucizumab for Dabigatran Reversal
2015 Standout
Ulcerative colitis
2020 Standout
Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
2010
Surgery and inhibitor development in hemophilia A: a systematic review
2011
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Management of Crohn's Disease in Adults
2009 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Intracellular Protein Delivery System with Protein Needle–GFP Construct
2014 StandoutNobel
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents
1992
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability
1995
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Cytosolic expression, solution structures, and molecular dynamics simulation of genetically encodable disulfide‐rich de novo designed peptides
2018 StandoutNobel
Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding
2013
Guidelines for the management of hemophilia
2012 Standout
Works of Gordon Em being referenced
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
1994
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
1985